Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kseniia Ievleva"'
Autor:
Ludmila Lazareva, Larisa Suturina, Alina Atalyan, Irina Danusevich, Iana Nadelyaeva, Lilia Belenkaya, Irina Egorova, Kseniia Ievleva, Natalia Babaeva, Daria Lizneva, Richard S. Legro, Ricardo Azziz
Publikováno v:
Diagnostics, Vol 14, Iss 7, p 673 (2024)
Polycystic ovary syndrome (PCOS) is a highly prevalent disorder in women, and its diagnosis rests on three principal features: ovulatory/menstrual dysfunction, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology (PCOM). Cu
Externí odkaz:
https://doaj.org/article/8be86f07d63a41cd900707179c4f87f8
Autor:
Sakshi Gera, Tan-Chun Kuo, Anisa Azatovna Gumerova, Funda Korkmaz, Damini Sant, Victoria DeMambro, Karthyayani Sudha, Ashley Padilla, Geoffrey Prevot, Jazz Munitz, Abraham Teunissen, Mandy MT van Leent, Tomas GJM Post, Jessica C Fernandes, Jessica Netto, Farhath Sultana, Eleanor Shelly, Satish Rojekar, Pushkar Kumar, Liam Cullen, Jiya Chatterjee, Anusha Pallapati, Sari Miyashita, Hasni Kannangara, Megha Bhongade, Puja Sengupta, Kseniia Ievleva, Valeriia Muradova, Rogerio Batista, Cemre Robinson, Anne Macdonald, Susan Hutchison, Mansi Saxena, Marcia Meseck, John Caminis, Jameel Iqbal, Maria I New, Vitaly Ryu, Se-Min Kim, Jay J Cao, Neeha Zaidi, Zahi A Fayad, Daria Lizneva, Clifford J Rosen, Tony Yuen, Mone Zaidi
Publikováno v:
eLife, Vol 11 (2022)
Pharmacological and genetic studies over the past decade have established the follicle-stimulating hormone (FSH) as an actionable target for diseases affecting millions, namely osteoporosis, obesity, and Alzheimer’s disease. Blocking FSH action pre
Externí odkaz:
https://doaj.org/article/0b0425ac3b2842fcad3a4a75380448c1
Autor:
Larisa Suturina, Natalia Belkova, Ilia Igumnov, Ludmila Lazareva, Irina Danusevich, Iana Nadeliaeva, Leonid Sholokhov, Maria Rashidova, Lilia Belenkaya, Aleksey Belskikh, Eldar Sharifulin, Kseniia Ievleva, Natalia Babaeva, Irina Egorova, Madinabonu Salimova, Mikhail Kuzmin, Daria Tiumentseva, Elizaveta Klimenko, Tuyana Sidorova, Alina Atalyan
Publikováno v:
Life, Vol 13, Iss 1, p 7 (2022)
Abnormalities in gut microbiota diversity are considered important mechanisms in metabolic disorders in polycystic ovarian syndrome (PCOS). However, the data on the association of these disorders with the PCOS phenotype remain controversial. The obje
Externí odkaz:
https://doaj.org/article/b3f72917d5a448c9afb2e8775023bd41
Autor:
Larisa Suturina, Daria Lizneva, Alina Atalyan, Ludmila Lazareva, Aleksey Belskikh, Tatyana Bairova, Leonid Sholokhov, Maria Rashidova, Irina Danusevich, Iana Nadeliaeva, Lilia Belenkaya, Zorikto Darzhaev, Eldar Sharifulin, Natalia Belkova, Ilia Igumnov, Tatyana Trofimova, Anastasiya Khomyakova, Kseniia Ievleva, Natalia Babaeva, Irina Egorova, Madinabonu Salimova, Bulent O. Yildiz, Richard S. Legro, Frank Z. Stanczyk, Ricardo Azziz
Publikováno v:
Diagnostics, Vol 13, Iss 1, p 33 (2022)
Androgen assessment is a key element for diagnosing polycystic ovary syndrome (PCOS), and defining a “normal” level of circulating androgens is critical for epidemiological studies. We determined the upper normal limits (UNLs) for androgens in a
Externí odkaz:
https://doaj.org/article/3395d4c1311f4edea7d4f25ad8397d23
Autor:
Kseniia Ievleva
Publikováno v:
Akusherstvo i ginekologiia. :5-12
Autor:
Jing Xiong, Seong Su Kang, Zhihao Wang, Xia Liu, Tan-Chun Kuo, Funda Korkmaz, Ashley Padilla, Sari Miyashita, Pokman Chan, Zhaohui Zhang, Pavel Katsel, Jocoll Burgess, Anisa Gumerova, Kseniia Ievleva, Damini Sant, Shan-Ping Yu, Valeriia Muradova, Tal Frolinger, Daria Lizneva, Jameel Iqbal, Ki A. Goosens, Sakshi Gera, Clifford J. Rosen, Vahram Haroutunian, Vitaly Ryu, Tony Yuen, Mone Zaidi, Keqiang Ye
Publikováno v:
Nature. 603:470-476
Autor:
Funda Korkmaz, Anisa Azatovna Gumerova, Tan-Chun Kuo, Sakshi Gera, Damini Sant, Victoria DeMambro, Karthyayani Sudha, Ashley Padilla, Geoffrey Prevot, Jazz Munitz, Abraham Teunissen, Mandy MT van Leent, Tomas GJM Post, Jessica C Fernandes, Jessica Netto, Farhath Sultana, Eleanor Shelly, Satish Rojekar, Pushkar Kumar, Liam Cullen, Jiya Chatterjee, Anusha Pallapati, Sari Miyashita, Hasni Kannangara, Megha Bhongade, Puja Sengupta, Kseniia Ievleva, Valeriia Muradova, Rogerio Batista, Cemre Robinson, Anne Macdonald, Susan Hutchison, Mansi Saxena, Marcia Meseck, John Caminis, Jameel Iqbal, Maria I New, Vitaly Ryu, Se-Min Kim, Jay J Cao, Neeha Zaidi, Zahi A Fayad, Daria Lizneva, Clifford J Rosen, Tony Yuen, Mone Zaidi
Publikováno v:
eLife. 11
Pharmacological and genetic studies over the past decade have established the follicle-stimulating hormone (FSH) as an actionable target for diseases affecting millions, namely osteoporosis, obesity, and Alzheimer’s disease. Blocking FSH action pre
Autor:
Funda Korkmaz, Anisa Azatovna Gumerova, Tan-Chun Kuo, Sakshi Gera, Damini Sant, Victoria DeMambro, Karthyayani Sudha, Ashley Padilla, Geoffrey Prevot, Jazz Munitz, Abraham Teunissen, Mandy MT van Leent, Tomas GJM Post, Jessica C Fernandes, Jessica Netto, Farhath Sultana, Eleanor Shelly, Satish Rojekar, Pushkar Kumar, Liam Cullen, Jiya Chatterjee, Anusha Pallapati, Sari Miyashita, Hasni Kannangara, Megha Bhongade, Puja Sengupta, Kseniia Ievleva, Valeriia Muradova, Rogerio Batista, Cemre Robinson, Anne Macdonald, Susan Hutchison, Mansi Saxena, Marcia Meseck, John Caminis, Jameel Iqbal, Maria I New, Vitaly Ryu, Se-Min Kim, Jay J Cao, Neeha Zaidi, Zahi A Fayad, Daria Lizneva, Clifford J Rosen, Tony Yuen, Mone Zaidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2dfd9cec54c485a66cbeff26c8bed89
https://doi.org/10.7554/elife.78022.sa2
https://doi.org/10.7554/elife.78022.sa2
Autor:
Daria Lizneva, Kseniia Ievleva, Anisa Gumerova, Eleanor Shelly, Funda Korkmaz, Valeriia Muradova, Jessica Netto, Tanchun Kuo, Farhath Sultana, Pushkar Kumar, Natan Kramskiy, Vitaly Ryu, Ashley Padilla, Susan Hutchison, Tony Yuen, Mone Zaidi
Publikováno v:
Journal of the Endocrine Society. 6:A27-A28
Menopause is associated with the loss of LH ovulatory surges and enhanced visceral adiposity. Visceral fat depots increase from 5-8% at premenopause to 15-20% of total body fat at postmenopause. Here, we report that high-dose LH, hCG, or small molecu
Autor:
Sakshi Gera, Tan-Chun Kuo, Funda Korkmaz, Damini Sant, Victoria DeMambro, Anisa Gumerova, Kathayani Sudha, Ashley Padilla, Geoffrey Prevot, Jazz Munitz, Abraham Teunissen, Mandy van Leent, Tomas G.J.M. Post, Jessica C. Fernandes, Jessica Netto, Farhath Sultana, Eleanor Shelly, Pushkar Kumar, Liam Cullen, Jiya Chatterjee, Sari Miyashita, Hasni Kannangara, Megha Bhongade, Kseniia Ievleva, Valeriia Muradova, Rogerio Batista, Cemre Robinson, Anne Macdonald, Susan Babunovic, Mansi Saxena, Marcia Meseck, John Caminis, Jameel Iqbal, Maria I. New, Vitaly Ryu, Se-Min Kim, Jay J. Cao, Neeha Zaidi, Zahi Fayad, Daria Lizneva, Clifford J. Rosen, Tony Yuen, Mone Zaidi
Pharmacological and genetic studies over the past decade have established FSH as an actionable target for diseases affecting millions, notably osteoporosis, obesity and Alzheimer’s disease (AD). Blocking FSH action prevents bone loss, fat gain and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6c2ddac0b44f0faf9f6545b16268fa4
https://doi.org/10.1101/2022.02.28.482279
https://doi.org/10.1101/2022.02.28.482279